Company: IPGP
Filing Date: 2025-04-07
Form Type: DEF 14A
Source: 0001111928-25-000054
Chunk: 37

Company: IPG PHOTONICS CORP
Filing Date: 2025-04-07
Form: DEF 14A
Chunk 37
---
 set for each NEO to support the Company’s strategic objectives and are tied to the areas of responsibilities of each NEO. Below is a summary of the primary 2024 objectives for each NEO who received a personal performance award in 2024 :

| Name            |     | 2024 Goals                                                                                                                                                                     |
| Timothy Mammen  |     | Update procedures and processes, complete and account for sale of Russian operations, implement new financial reporting and analysis, improve and develop finance organization |
| Trevor Ness     |     | Improve management of medical business, achieve sales targets, support systems business success and corporate development activities                                           |
| Angelo Lopresti |     | Assist in CEO transition, complete sale of Russian operations, support corporate development activities, improve and develop legal department                                  |
| Igor Samartsev  |     | Increase innovation and reliability in engineering solutions, accelerate time to market for new products, improve innovations pipeline                                         |

37

#### 2024 Compensation of Named Executive Officers
In addition, a portion of the individual performance achievement for each NEO was based on increasing collaboration within the leadership team and functional group. The Compensation Committee evaluated individual performance of each non-CEO NEO employed at year-end based Dr. Gitin’s recommendation, which was based on his assessment of their individual achievement of 2024 goals. The individual performance achievement for each of the non-CEO NEOs employed at year-end is set forth in the table below.

#### 2024 Payouts
The table below includes the Revised AIP payouts to our NEOs in office at the end of 2024. Drs. Scherbakov and Ovtchinnikov were not eligible to receive bonuses under the 2024 AIP and Dr. Gitin did not participate in the Revised AIP in light of his new hire bonus.

|                 |     |        |          |               | Target(1)   |    |   |     |    |                                          |             |    |   |             |          |     | Actual |     |           |   |     |       |          |     |          |         |          |      |   |
| Name            |     | Annual 
 Base   
 Salary |          |               | Target      
 Annual      
 Incentive % |    |   |     |    | Corporate Performance Target (weighting) | Personal    
 Performance 
 Target      
 (weighting) |    |   | Target      
 Annual      
 Incentive $ |          |     |        |     | Financial |   |     |